# Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Peramivir in Children With Influenza

> **NCT01063933** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)**

## Conditions studied

- Influenza

## Interventions

- **DRUG:** Peramivir

## Key facts

- **NCT ID:** NCT01063933
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2011-08
- **Final completion:** 2012-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2011-11-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01063933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01063933, "Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Peramivir in Children With Influenza". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01063933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*